For more than 125 years, Johnson & Johnson has advanced the health and well-being of women, children and families around the world. We bring innovation, expertise and unique resources to the partnerships that make life-changing, long-term improvements in human health, especially in places where resources are most scarce.
In 2010, Johnson & Johnson responded to the UN Secretary General’s Call-to-Action for a renewed global effort to advance the Millennium Development Goals with a comprehensive, five-year commitment to reach as many as 120 million women and children per year by 2015, especially in areas where resources are most scarce.
Two years into the commitment, we have made real progress by expanding the number of health workers, piloting innovations and scaling up proven global health interventions in the following areas:
The map below highlights partnerships and programs focusing on frontline healthcare workers for women and children in more than 35 countries.
Infographic: Supporting frontline health workers
Fact Sheet: Expanding the Frontline Health Workforce to Care for Women and Children
Our MDG Focus Areas for Women and Children:
Making Childbirth Safer
Every year, 280,000 mothers die from complications in pregnancy and child birth and at least 3.1 million newborns die in the fragile first month of life. We partner with organizations around the world to help every mother and newborn survive and thrive. Infographic: Midwives save lives |
|
Reaching Mothers with Life-Saving Health Information through Their Mobile Phones
More than 1 billion women in low- and middle-income countries own a mobile phone. Together with partner organizations, we support programs that deliver vital health information to new and expectant mothers through mobile phones. Fact Sheet: Empowering Mothers with Health Education through Their Mobile Phones |
|
Eliminating Mother to Child HIV Transmission
Every year, 330,000 babies become infected with HIV because they are born to mothers living with HIV. These infections are preventable with access to care and information. In collaboration with partners, we invest in proven programs and pioneering groundbreaking models to reduce the number of children born with HIV and reduce the number of mothers dying of AIDS. |
|
Treating Children At-Risk for Intestinal Worms and Preventing the Cycle of Reinfection
More than 600 million of the nearly 1.2 billion people infected by or at-risk of infection from intestinal worms are school-age children. Children Without Worms, a partnership formed between The Task Force for Global Health and Johnson & Johnson in 2006 is working toward a world where children are free of intestinal worms, and are able to play, learn and grow into healthy adults. |
|
Increasing Research and Development for New Medicines
We are committed to the ongoing research & development of new medicines to treat diseases affecting people living in the developing world, including women and children. These efforts include research and development dedicated to finding new, effective treatments for HIV/AIDS, tuberculosis, and neglected tropical diseases. |
|
For more than 125 years, Johnson & Johnson has advanced the health and well-being of women, children and families around the world. We bring innovation, expertise and unique resources to the partnerships that make life-changing, long-term improvements in human health, especially in places where resources are most scarce.
In 2010, Johnson & Johnson responded to the UN Secretary General’s Call-to-Action for a renewed global effort to advance the Millennium Development Goals with a comprehensive, five-year commitment to reach as many as 120 million women and children per year by 2015, especially in areas where resources are most scarce.
Two years into the commitment, we have made real progress by expanding the number of health workers, piloting innovations and scaling up proven global health interventions in the following areas:
The map below highlights partnerships and programs focusing on frontline healthcare workers for women and children in more than 35 countries.
Infographic: Supporting frontline health workers
Fact Sheet: Expanding the Frontline Health Workforce to Care for Women and Children
Our MDG Focus Areas for Women and Children:
|
Making Childbirth Safer Making Childbirth Safer Every year, 280,000 mothers die from complications in pregnancy and child birth and at least 3.1 million newborns die in the fragile first month of life. We partner with organizations around the world to help every mother and newborn survive and thrive. Infographic: Midwives save lives |
|
|
Reaching Mothers with Life-Saving Health Information through Their Mobile Phones Reaching Mothers with Life-Saving Health Information through Their Mobile Phones More than 1 billion women in low- and middle-income countries own a mobile phone. Together with partner organizations, we support programs that deliver vital health information to new and expectant mothers through mobile phones. Fact Sheet: Empowering Mothers with Health Education through Their Mobile Phones |
|
|
Eliminating Mother to Child HIV Transmission Eliminating Mother to Child HIV Transmission Every year, 330,000 babies become infected with HIV because they are born to mothers living with HIV. These infections are preventable with access to care and information. In collaboration with partners, we invest in proven programs and pioneering groundbreaking models to reduce the number of children born with HIV and reduce the number of mothers dying of AIDS. |
|
|
Treating Children At-Risk for Intestinal Worms and Preventing the Cycle of Reinfection More than 600 million of the nearly 1.2 billion people infected by or at-risk of infection from intestinal worms are school-age children. Children Without Worms, a partnership formed between The Task Force for Global Health and Johnson & Johnson in 2006 is working toward a world where children are free of intestinal worms, and are able to play, learn and grow into healthy adults. |
|
|
Increasing Research and Development for New Medicines We are committed to the ongoing research & development of new medicines to treat diseases affecting people living in the developing world, including women and children. These efforts include research and development dedicated to finding new, effective treatments for HIV/AIDS, tuberculosis, and neglected tropical diseases. |